[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-350466-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-350466-en":131},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","synergistic-anticancer-activity-of-antimicrobial-peptide-nisin-and-doxorubicin-against-breast-cancer-cells-via-modulation-of-membrane-permeability","Synergistic anticancer activity of antimicrobial peptide nisin and doxorubicin against breast cancer cells via modulation of membrane permeability","","Breast cancer is the most frequently diagnosed cancer and a leading cause of death among females. To improve therapeutic effectiveness, the study evaluates combination therapy using nisin, a cationic antimicrobial peptide, and doxorubicin (DOX). Nisin preferentially permeabilizes membranes with anionic lipids, and both agents are tested on MCF-7 and MDA-MB-231 cells. Bliss independence shows synergy in MCF-7 under selected concentrations, with enhanced membrane permeability, DNA damage, and apoptosis.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/synergistic-anticancer-activity-of-antimicrobial-peptide-nisin-and-doxorubicin-against-breast-cancer-cells-via-modulation-of-membrane-permeability/350466/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/synergistic-anticancer-activity-of-antimicrobial-peptide-nisin-and-doxorubicin-against-breast-cancer-cells-via-modulation-of-membrane-permeability/350466.png","ImageObject",300,407,{"name":42,"@type":43},"Aran","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-17","2026-09-22",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",11,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"How does nisin influence cancer cells in this study?","Question",{"text":63,"@type":64},"Nisin preferentially permeabilizes membranes associated with anionic lipids, promoting downstream effects such as DOX entry, DNA damage, and apoptosis.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"Which breast cancer cell lines were used to evaluate treatment effects?",{"text":68,"@type":64},"The study uses two breast cancer cell lines: MCF-7 and MDA-MB-231.",{"name":70,"@type":61,"acceptedAnswer":71},"What evidence supports synergy between nisin and doxorubicin?",{"text":72,"@type":64},"Bliss independence analysis indicates a markedly synergistic effect between nisin and DOX in MCF-7 under specific dosing conditions.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},350466,1790112671,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,115,120,123,127],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":112,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":113,"slug":114},8,30,"research-report",{"id":116,"doc_module":4,"doc_module_name":25,"category_name":117,"show_sort_weight":118,"slug":119},9,"Religion & Spirituality",20,"religion-spirituality",{"id":118,"doc_module":4,"doc_module_name":25,"category_name":121,"show_sort_weight":118,"slug":122},"World Cup","world-cup",{"id":124,"doc_module":4,"doc_module_name":25,"category_name":125,"show_sort_weight":124,"slug":126},10,"Lifestyle","lifestyle",{"id":128,"doc_module":4,"doc_module_name":25,"category_name":129,"show_sort_weight":97,"slug":130},19,"General","general",{"code":4,"msg":82,"data":132},{"doc_id":79,"user_id":133,"nickname":42,"user_avatar":134,"doc_module":4,"category_id":112,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":140,"language":141,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":142,"faqs":143,"seo_title":144,"seo_description":12,"update_tm":145,"read_time":146,"preview_page_count":30,"preview_urls":147},137455076865,"https://ap-avatar.wpscdn.com/davatar_29158cc5080c5b710cf443261637dec0","OPEN ACCESS  \nCitation: Phetdee C, Naephrai S, Pradain M, Panporm Y, Ahmad U, Prangkio P (2026) Synergistic anticancer activity of antimicrobial peptide nisin and doxorubicin against breast cancer cells via modulation of membrane permeability. PLoS One 21(6): e0352312 .  \n[https://doi.org/10.1371/journal.pone.0352312](https://doi.org/10.1371/journal.pone.0352312)[ ](https://doi.org/10.1371/journal.pone.0352312)[Editor:](Editor: Alexandra Lianou)[ Alexandra Lianou](Editor: Alexandra Lianou), University of Patras, GREECE  \nReceived: February 4, 2026  \nAccepted: June 5, 2026  \nPublished: June 23, 2026  \nPeer Review History: PLOS recognizes the benefits of transparency in the peer review process; therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. The editorial history of this article is available here: [https://doi.org/10.1371/journal](https://doi.org/10.1371/journal). pone.0352312  \nCopyright: © 2026 Phetdee et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution,  \nRESEARCH ARTICLE  \nSynergistic anticancer activity of antimicrobial peptide nisin and doxorubicin against breast cancer cells via modulation of membrane permeability  \nChanita Phetdee1, Suwatjanee Naephrai1,2, Malinee Pradain1, Yanisa Panporm1,2, Ubaid Ahmad1,2, Panchika Prangkio1,3*  \n1 Department of Chemistry, Faculty of Science, Chiang Mai University, Chiang Mai, Thailand, 2 Program in Biotechnology, Multidisciplinary and Interdisciplinary School, Chiang Mai University, Chiang Mai, Thailand, 3 Center of Excellence in Materials Science and Technology, Faculty of Science, Chiang Mai University, Chiang Mai, Thailand  \n* [panchika.p@cmu.ac.th](panchika.p@cmu.ac.th)  \nAbstract  \nBreast cancer is the most frequently diagnosed cancer and remains the leading cause of death among females. Despite the rapid advancement in cancer therapy, the development of more effective therapeutic strategies and anticancer agents with a new mode of action remains a critical challenge. Combination of therapeutic agents is an attractive approach to enhance drug efficacy. Nisin, a cationic antimicrobial peptide, has been reported for its cytotoxicity against some cancer cell lines via several mechanisms, particularly membrane disruption. Nisin can bind preferentially to the negatively charged phospholipids, causing pore formation in cell membranes. In this study, we demonstrated that nisin exhibited membrane permeabilization preferentially with anionic lipids using liposomal leakage assay. Moreover, anticancer activity of nisin and doxorubicin (DOX) was investigated against two breast cancer cell lines, MCF-7 and MDA-MB-231, using MTT assay. Nisin demonstrated cytotoxic effect against breast cancer MCF-7 and MDA-MB-231, with IC50 values of 5–8 µM, while exhibiting lower cytotoxicity toward normal cells. Based on Bliss independence analysis, the synergistic effect between nisin and DOX was markedly observed in MCF-7 when treated with 10 μM nisin and 1 μM DOX for 24–48 h treatment. Furthermore, as demonstrated by fluorescent-based high-content analysis, nisin clearly caused cell membrane permeability and promoted DOX-induced DNA damage in both cell lines. Flow cytometry with Annexin-V staining revealed that co-treatment of nisin and DOX significantly enhanced apoptosis, as compared to individual treatments, particularly in MCF-7 cells, suggesting a key mechanism of action for anticancer activity. Cationic nisin can interact with biological membrane and modulate membrane permeability and fluidity, consequently facilitating DOX entry, inducing apoptosis and DNA damage. Overall, this study demonstrates that the combination of nisin and DOX could  \nPLOS One | [https://doi.org/10.1371/journal.pone.0352312](https://doi.org/10.1371/journal.pone.0352312) June 23, 2026 1 / 23  \nand reproduction in any medium, provided the ori","cbCainROhhFkrkBO","https://ap.wps.com/l/cbCainROhhFkrkBO","pdf",2523284,23,"English","# Abstract\n## Introduction\n## Materials and Methods\n## Results and Discussion\n## Conclusion","[{\"question\":\"How does nisin influence cancer cells in this study?\",\"answer\":\"Nisin preferentially permeabilizes membranes associated with anionic lipids, promoting downstream effects such as DOX entry, DNA damage, and apoptosis.\"},{\"question\":\"Which breast cancer cell lines were used to evaluate treatment effects?\",\"answer\":\"The study uses two breast cancer cell lines: MCF-7 and MDA-MB-231.\"},{\"question\":\"What evidence supports synergy between nisin and doxorubicin?\",\"answer\":\"Bliss independence analysis indicates a markedly synergistic effect between nisin and DOX in MCF-7 under specific dosing conditions.\"}]","Synergistic anticancer activity of antimicrobial peptide nisin and doxorubicin against breast cancer cells via modulation of membrane permeability | PDF",1790089197,58,[148,152,156],{"page_no":22,"url":149,"width":150,"height":151},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-08/157841ed26b37b5bdfec5b96029f8c54.webp",983,1272,{"page_no":26,"url":153,"width":154,"height":155},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-08/48cd4dad64dd90b312a02ac82ef8ee5c.webp",982,1270,{"page_no":30,"url":157,"width":158,"height":159},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-08/6927ac6026f8ff58f3c28c9e8445bc8e.webp",981,1269]